Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

2.990 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
SaponiQx Announces Breakthrough in Scaling Up of STIMULON™ Cultured Plant Cell Adjuvant
From SaponiQx
Via Business Wire
News headline image
Agenus Reports Second Quarter 2023 Results
From Agenus Inc.
Via Business Wire
News headline image
Agenus Botensilimab/Balstilimab Data Update in Sarcomas Selected for Oral Presentation at ESMO 2023
From Agenus Inc.
Via Business Wire
News headline image
Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update
From Agenus
Via Business Wire
News headline image
Agenus (AGEN) Q1 2023 Earnings Call Transcript ↗
AGEN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
Agenus' Investigational Cancer Combo Therapy Shows 33% Durable Responses In Ovarian Cancer ↗
 
Via Benzinga
News headline image
Why Agenus Stock Is Slumping This Week ↗
The biotech may have to raise capital soon. 
Via The Motley Fool
News headline image
Agenus Expands Executive Leadership Team
From Agenus Inc.
Via Business Wire
News headline image
ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer
From Agenus
Via Business Wire
News headline image
2 Low-Priced Stocks That Could Make You Richer ↗
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 6, 2023 ↗
 
Via Benzinga
News headline image
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolvency Court of Munich, Germany, to permit opening of self-administration proceeding. 
Via Benzinga
News headline image
Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO
From Agenus Inc.
Via Business Wire
News headline image
Agenus (AGEN) Q4 2022 Earnings Call Transcript ↗
AGEN earnings call for the period ending December 31, 2022. 
Via The Motley Fool
News headline image
Agenus Announces Virtual Annual Shareholders Meeting
From Agenus
Via Business Wire
News headline image
Agenus to Participate in Jefferies Healthcare Conference
From Agenus
Via Business Wire
News headline image
Agenus Provides Corporate Update and First Quarter 2023 Financial Results
From Agenus Inc.
Via Business Wire
News headline image
Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI
From Agenus
Via Business Wire
Agenus (NASDAQ: AGEN) Featured in Coverage of the Inaugural EF Hutton Global Conference
Via Investor Brand Network
News headline image
Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting
From Agenus
Via Business Wire
News headline image
Agenus to Provide Corporate Update and First Quarter 2023 Financial Report
From Agenus
Via Business Wire
News headline image
Agenus to Participate in May Investor Conferences
From Agenus
Via Business Wire
News headline image
Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
Via Benzinga
News headline image
These 3 Nasdaq Stocks Are on Fire Today: Here's Why ↗
A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today. 
Via The Motley Fool
News headline image
Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer
From Agenus Inc.
Via Business Wire
News headline image
Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
From Gain Therapeutics, Inc.
Via GlobeNewswire
News headline image
Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today ↗
Macro headwinds are weighing on risk-laden biotech stocks today. 
Via The Motley Fool
News headline image
Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
From Agenus Inc.
Via Business Wire
News headline image
Agenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer
From Agenus Inc.
Via Business Wire
News headline image
Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives
From Agenus Inc.
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.